Abstract: Objective To explore the clinical value of interventional invasive therapy in primary hepatocellular carcinoma (PHCC) and it' s radical efficacy. Methods The retrospective analysis was undertaken in 538 patients between January 2003 and January 2008 in our hospital with PHCC. The treatment and the radical efficacy were evaluated. Results Twenty patients(3.7%, 20/538) get progression after the first treatment, 518 patients (518/538) had ever gained effective cure, of whom progression occurred in 416 patients (77.3%, 416/538)at last. The earliest progression occurred 4 months after the first therapy, and the latest occurred 24 months later. One hundred and two (19.0%, 102/538) patients gained evident effective cure, 53 of whom gained radical cure, and they are still alive. The longest follow-up time was 64 months, the shortest was 16 months, and the median survival span estimation in the recent follow-up was 36.5 months. Conclusion Comprehensive interventional therapy is an effective and safe therapy for PHCC, and some patients can gain radical cure.